Revolutionary System Maps and Ablates Atrial Arrhythmias and Provides Real-Time Feedback
|
By HospiMedica International staff writers Posted on 17 Mar 2023 |
|
Atrial fibrillation (AFib) is the most prevalent atrial arrhythmia globally, affecting approximately 60 million people worldwide. By 2030, an estimated five million more patients will be diagnosed each year. Atrial arrhythmias, including AFib, can lead to severe complications such as heart failure, stroke, and an increased risk of mortality. To address these challenges, the first-of-its-kind catheter with pulsed-field ablation, radiofrequency, and high-density mapping that is integrated with an intuitive mapping and navigation platform improves efficiency and enhances the safety of ablation procedures for patients.
The Affera Mapping and Ablation System from Medtronic plc (Dublin, Ireland), which includes the Sphere-9 Catheter and the Affera Prism-1 Mapping Software, marks a breakthrough in electrophysiology by integrating the Sphere-9 pulsed field ablation (PFA), radiofrequency (RF), and high density (HD) mapping catheter, which maps and ablates atrial arrhythmias (fast, abnormal heart rhythms) and provides real-time feedback using its intuitive mapping and navigation software.
The Sphere-9 Catheter, combined with the integrated mapping and navigation system, instantly generates sophisticated electro-anatomical maps, enabling physicians to administer wide-area focal ablation lesions of choice between RF or PFA, depending upon the requirements of the patient and procedure. Considering its size, the all-in-one catheter's nitinol 9mm ablation tip will need fewer focal ablation lesion applications that can reduce procedure times as compared to standard irrigated ablation catheters. The intuitive mapping software provides a highly optimized user experience by offering streamlined insights and feedback to support procedure performance.
Medtronic has received CE (Conformité Européenne) Mark for the Affera Mapping and Ablation System, based on results from clinical studies assessing the safety and performance of the Sphere-9 Catheter and Mapping System. The CE Mark approval comes on the back of the December 2022 announcement of the completion of enrollment for the Affera SPHERE Per-AF Clinical Trial, a randomized, controlled U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal trial. The SPHERE PER-AF IDE trial aims to investigate the safety and efficacy of the Affera Mapping and Ablation System in treating persistent atrial fibrillation. Currently, the trial is in its 12-month follow-up phase. The Affera Mapping and Ablation System will be available for commercial use in Europe by the first half of 2023, whereas it is still in the investigational stage in the U.S.
"The revolutionary Affera Mapping and Ablation System combined with the novel Sphere-9 Catheter represent a great advancement in the field of HD mapping and focal ablation," said Khaldoun Tarakji, M.D., MPH, vice president, chief medical officer, Cardiac Ablation Solutions business, which is part of the Cardiovascular Portfolio at Medtronic. "Current technologies require the use of separate HD mapping and ablation catheters. The ability to map, ablate, and validate with the Sphere-9 Catheter enables the physician to eliminate the need to exchange catheters and empowers them to choose the energy source, whether RF or PF, based on the patient's needs. All this leads to improving efficiency and most importantly, enhancing the safety of ablation procedures for our patients."
Related Links:
Medtronic plc
Latest Surgical Techniques News
- Microgrippers For Miniature Biopsies to Create New Cancer Diagnostic Screening Paradigm
- Miniature Soft Lithium-Ion Battery Could Be Used as Defibrillator During Surgery
- TAVI Procedure Supported by Radial Artery Access Reduces Bleeding Complications
- Portable Surgical Robot Seamlessly Integrates into Any OR for Performing Cholecystectomy Procedures
- New Thoracic Surgery Risk Calculators Support Preoperative Decision-Making
- Surgical Platform with Miniature Humanoid-Shaped Robotic Arms Provides Human Level Dexterity
- Precision Surgical Technique Enables Lymph Node Detection and Removal in Endometrial Cancer
- Glowing Approach Helps Surgeons Assess Neural Blood Flow in Chronic Nerve Compression Neuropathy
- Predictive Model Identifies Best Patients for Minimally Invasive Epilepsy Surgery
- Light-Driven Micro-Robot Designed to Swim Autonomously in Viscous Liquids Could Be Used for Unblocking Blood Vessels
- Novel Approach Combines Advanced Robotics and Low-Field MRI Technology for Incisionless Prostate Surgery
- Fast OCT System Integrated into Neurosurgical Microscope Identifies Tumor Margins During Brain Surgery
- Miniature Robots Transport Instruments for Endoscopic Microsurgery Through Body
- Robotic Visualization System for Neurosurgery Offers Greater Clarity for Complex Procedures
- Endometrial Ablation for Abnormal Uterine Bleeding Associated with High Risk of Hysterectomy
- Breakthrough Robot Technology Could Allow Entire Surgery to Be Performed Without Human Intervention
Channels
Critical Care
view channel_1.jpg "mage: The electroceutical epidermal patch is designed to inhibit bacterial growth (Photo courtesy of Saehyun Kim/University of Chicago)")
Cutting-Edge Bioelectronic Device Offers Drug-Free Approach to Managing Bacterial Infections
Antibiotic-resistant infections pose an increasing threat to patient safety and healthcare systems worldwide. Recent estimates indicate that drug-resistant infections may rise by 70% by 2050, highlighting... Read more
Sophisticated Machine-Learning Approach Uses Patient EHRs to Predict Pneumonia Outcomes
Pneumonia, an infection that results in difficulty breathing due to fluid accumulation in the lungs, is one of the leading causes of death worldwide. This condition is particularly challenging to treat... Read more
Early TAVR Benefits Patients with Asymptomatic Severe Aortic Stenosis
For patients with asymptomatic severe aortic stenosis (AS) and preserved left-ventricular ejection fraction, current guidelines recommend clinical surveillance every six to twelve months.... Read more
First-Of-Its-Kind Experimental Therapy Enhances Tissue Repair After Heart Attack
Cardiovascular disease remains the leading cause of death worldwide, accounting for one-third of all annual fatalities. Following a heart attack, the heart's natural regenerative ability is limited, resulting... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read more
Business
view channel
Hologic Acquires Gynesonics to Strengthen Existing Gynecological Surgical Business
Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Gynesonics (Redwood City, CA, USA) for approximately USD 350 million, subject to working capital and other customary closing adjustments.... Read more
